126 / 140
Guía OncoSur de sarcomas de partes blandas
126
>
Tumor desmoide
58. Rock MG, Pritchard DJ, Reiman HM, et al. Extra-abdominal desmoid tumors. J Bone Joint Surg Am
1984;66:1369.
59. Brooks MD, Ebbs SR, Colletta AA, et al. Desmoid tumours treated with triphenylethylenes. Eur J Cancer
1992;28A:1014.
60. Tonelli F, Ficari F, Valanzano R, et al. Treatment of desmoids and mesenteric fibromatosis in familial adeno-
matous polyposis with raloxifene. Tumori 2003;89:391.
61. Fiore M, Colombo C, Radaelli S, et al. Hormonal manipulation with toremifene in sporadic desmoid-type
fibromatosis. Eur J Cancer 2015;51:2800.
62. Tsukada K, Church JM, Jagelman DG, et al. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in
patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35:29.
63. Heinrich MC, McArthur GA, Demetri GD, et al. Clinical and molecular studies of the effect of imatinib on
advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006;24:1195.
64. Penel N, Le Cesne A, Bui BN, et al. Imatinib for progressive and recurrent aggressive fibromatosis (des-
moid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol
2011;22:452.
65. Chugh R, Wathen JK, Patel SR, et al. Efficacy of imatinib in aggressive fibromatosis: results of a phase II multi-
center Sarcoma Alliance for Research through Collaboration (SARC) Trial. Clin Cancer Res 2010;16:4884-91.
66. Gounder MM, Lefkowitz RA, Keohan ML, et al. Activity of Sorafenib against desmoid tumor/ deep fibroma-
tosis. Clin Cancer Res 2011;17:4082-90.
67. Garbay D, Le Cesne A, Penel N, et al. Chemotherapy in patients with desmoid tumors: a study from the French
Sarcoma Group (FSG). Ann Oncol 2012;23:182-6.
68. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993;72:3244.
69. Azzarelli A, Gronchi A, Bertulli R, et al. Low-dose chemotherapy with methotrexate and vinblastine for pa-
tients with advanced aggressive fibromatosis. Cancer 2001;92:1259.
70. Weiss AJ, Horowitz S, Lackman RD. Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J
Clin Oncol 1999;22:193.
Tumor fibroso solitario/hemagiopericitoma
71. Wong PP, Yagda A. Chemotherapy of malignant hemangiopericytoma. Cancer 1978;41:1256-60.
72. Beadle GF, Hillcoat BL. Treatment of advanced malignant hemangiopericytoma with combination adriamycin
and DTIC: a report of four cases. J Surg Oncol 1983;22:167-70.
73. Stacchiotti S, Libertini M, Negri T, et al. Response to chemotherapy of solitary fibrous tumour: a retrospective
study. Eur J Cancer 2013;49:2376-83.
74. Park MS, Patel S, Ravi V, et al. The role of chemotherapy in advanced hemangiopericytoma/solitary fibrous
tumor. Clin Sarcoma Res 2013;3:7
75. Chaigneau L, Kalbacher E, Thiery-Vuillemin A, et al. Efficacy of trabectedin in metastatic solitary fibrous
tumor. Rare Tumors 2011;3:e29.
76. Martínez-Trufero J, Alfaro J, Felipo F, et al. Response to trabectedin treatment in a highly pretreated patient
with an advanced meningeal hemangiopericytoma. Anticancer Drugs 2010;21:795-8.
77. Park MS, Patel SR, Ludwig JA, et al. Activity of temozolomide and bevacizumab in the treatment of lo-
cally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer
2011;117:4939-47.
78. Mulamalla K, Truskinovsky AM, Dudek AZ. Rare case of hemangiopericytoma responds to sunitinib. Transl
Res 2008;151:129-33.
79. Stacchiotti S, Negri T, Libertini M, et al. Sunitinib in solitary fibrous tumor. Ann Oncol 2012;23:3171-9.
80. Stacchiotti S, Negri T, Palassini E, et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns
and molecular bases of tumor response. Mol Cancer Ther 2010;9:1286-97.
81. Domont J, Massard C, Lassau N, et al. Hemangiopericytoma and antiangiogenic therapy: clinical benefit of
antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma/solitary fibrous
tumour. Invest New Drugs 2010;28:199-202.